Rapilysin Lyophilisat
Country: Switzerland
Language: German
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
reteplasum
Available from:
Mepha Pharma AG
ATC code:
B01AD07
INN (International Name):
reteplasum
Pharmaceutical form:
Lyophilisat
Composition:
Praeparatio cryodesiccata: reteplasum 10 U., acidum tranexamicum, acidum phosphoricum, dikalii phosphas trihydricus, saccharum, polysorbatum 80, pro vitro. Solvens: aqua ad iniectabilia 10 ml.
Therapeutic group:
Biotechnologika
Therapeutic area:
Thrombolytische Therapie bei akutem Herzinfarkt
Authorization date:
1996-12-20
